- Conditions
- COVID, Corona Virus Infection, COVID19
- Interventions
- Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University., Placebo
- Biological · Other
- Lead sponsor
- Joanne Kurtzberg, MD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 5
- States / cities
- Boca Raton, Florida • Miami, Florida • Valhalla, New York + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 193–216
of 3,924
matching trials from the live ClinicalTrials.gov search.
- Conditions
- COVID-19
- Interventions
- FSD201, Placebo, Standard of Care for Covid-19
- Drug · Other
- Lead sponsor
- Quantum Biopharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 10
- States / cities
- Miami, Florida • St. Petersburg, Florida • Idaho Falls, Idaho + 6 more
- Conditions
- COPD, Chronic Obstructive Pulmonary Disease, Dyspnea, Breathlessness, Emphysema, Chronic Bronchitis
- Interventions
- Melodica Intervention, Pulmonary Health Education
- Behavioral
- Lead sponsor
- VA Quality Enhancement Research Intiative
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Influenza
- Interventions
- Ear Loop Procedure Mask, 62% Ethyl Alcohol Hand Sanitizer
- Behavioral
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,420 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Influenza Vaccine
- Interventions
- Cam2020 M2SR H3N2 influenza vaccine, Fluzone HD IIV, IN Placebo, IM Placebo
- Biological · Other
- Lead sponsor
- FluGen Inc
- Industry
- Eligibility
- 65 Years to 85 Years
- Enrollment
- 303 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 6
- States / cities
- Port Orange, Florida • Meridian, Idaho • Lenexa, Kansas + 3 more
- Conditions
- Tetanus, Diphtheria, Pertussis
- Interventions
- Tetanus-diphtheria-acellular pertussis (Tdap) vaccine
- Biological
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Eligibility
- 15 Years to 69 Years
- Enrollment
- 545 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2008
- U.S. locations
- 4
- States / cities
- Jonesboro, Arkansas • Bossier City, Louisiana • University Heights, Ohio + 1 more
- Conditions
- Covid19, SARS-CoV2 Infection
- Interventions
- Focal Mask
- Device
- Lead sponsor
- Georgia Institute of Technology
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 201 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Bronchiolitis
- Interventions
- NoseFrida
- Device
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 2 Months to 2 Years
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2019
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- COVID-19
- Interventions
- Navigation Services, Brief Counseling, Critical Dialogue, Referral and Digital Brochure
- Behavioral
- Lead sponsor
- University of Illinois at Urbana-Champaign
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 554 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- East Saint Louis, Illinois
- Conditions
- COVID-19
- Interventions
- Decitabine, Placebo Saline
- Drug · Other
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- COVID-19
- Interventions
- Bamlanivimab, Etesevimab, Placebo, VIR-7831, Bebtelovimab
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 1,755 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 127
- States / cities
- Birmingham, Alabama • Mesa, Arizona • Scottsdale, Arizona + 103 more
- Conditions
- Treatment of Chronic Obstructive Pulmonary Disease
- Interventions
- Guideline treatment recommendations
- Other
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- Not listed
- Enrollment
- 181 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2021
- U.S. locations
- 2
- States / cities
- Bedford, Massachusetts • Seattle, Washington
- Conditions
- Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2
- Interventions
- Drug: NA-831, NA-831 and Atazanavir, NA-831and Dexamethasone, Atazanavir and Dexamethasone
- Drug · Combination Product
- Lead sponsor
- Biomed Industries, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 525 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 31
- States / cities
- Los Angeles, California • Orange, California • Palo Alto, California + 27 more
- Conditions
- Covid19, SARS-CoV Infection, Coronavirus Infection
- Interventions
- Camostat Mesilate, Bicalutamide 150 mg
- Drug
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Other
- Eligibility
- 60 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Pneumonia
- Interventions
- Salmonella Typhi-vectored pneumonia vaccine
- Biological
- Lead sponsor
- Arizona State University
- Other
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Long COVID, Long Covid19
- Interventions
- Narrative Intervention for Long COVID-19 (NICO)
- Behavioral
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- HIV, Cancer
- Interventions
- Fluzone High Dose Vaccine, Fluzone Standard Dose Vaccine
- Biological
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Eligibility
- 3 Years to 21 Years
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- COVID-19, Influenza A, Influenza Type B
- Interventions
- COVID-19/ Flu A&B Rapid Panel
- Device
- Lead sponsor
- Abbott Rapid Diagnostics Jena GmbH
- Industry
- Eligibility
- Not listed
- Enrollment
- 2,472 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Easley, South Carolina
- Conditions
- Congenital Heart Disease, Comorbidities and Coexisting Conditions
- Interventions
- Impact of gaps in care/loss to healthcare follow-up
- Other
- Lead sponsor
- Children's National Research Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 16
- States / cities
- San Francisco, California • Aurora, Colorado • Washington D.C., District of Columbia + 9 more
- Conditions
- COPD, Chronic Obstructive Pulmonary Disease
- Interventions
- BIO-11006 Inhalation Solution, Placebo, BIO-11006
- Drug
- Lead sponsor
- BioMarck Pharmaceuticals, Ltd.
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 172 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 14
- States / cities
- Glendale, Arizona • Los Angeles, California • Bay Pines, Florida + 10 more
- Conditions
- Sinusitis
- Interventions
- XprESS Balloon Device
- Device
- Lead sponsor
- Entellus Medical, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 175 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Bronchiolitis
- Interventions
- De-implementation Strategy for Bronchiolitis
- Behavioral
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 1 Month to 80 Years
- Enrollment
- 20,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 3
- States / cities
- Aurora, Colorado • Columbus, Ohio • Seattle, Washington
- Conditions
- Pneumonia, Pulmonary Disease, Lung Disease
- Interventions
- Not listed
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- NIH
- Eligibility
- 3 Years to 99 Years
- Enrollment
- 750 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2004
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Influenza Immunization, Health Volunteers
- Interventions
- Trivalent Recombinant Influenza Vaccine
- Biological
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,007 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Swiftwater, Pennsylvania